| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Diabetic Neuropathies | D003929 | 5 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Dilatation, Pathologic | D004108 | 5 associated lipids |
| Disease Susceptibility | D004198 | 12 associated lipids |
| Emphysema | D004646 | 1 associated lipids |
| Encephalitis | D004660 | 15 associated lipids |
| Endocrine System Diseases | D004700 | 4 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Eye Neoplasms | D005134 | 2 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Gautam J et al. | An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. | 2016 | J. Pharm. Pharmacol. | pmid:27265669 |
| Owen S et al. | Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. | 2016 | Int. J. Oncol. | pmid:26781475 |
| Maser RE et al. | Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. | 2016 | J. Diabetes Complicat. | pmid:26775555 |
| Gottesman GS et al. | Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. | 2016 | Am. J. Med. Genet. A | pmid:26762549 |
| Totoson P et al. | Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation. | 2016 | PLoS ONE | pmid:26761790 |
| Kim CS et al. | Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. | 2016 | PLoS ONE | pmid:27855207 |
| Li XJ et al. | Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. | 2016 | Int. J. Mol. Med. | pmid:27840967 |
| Ye C et al. | [Effect of MT01/PEN complexes on the expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in human osteoblast-like cell line MG63]. | 2016 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:27266195 |
| Bernardi S et al. | Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. | 2016 | Biomed Res Int | pmid:27200369 |
| Wei CC et al. | Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis. | 2016 | Mediators Inflamm. | pmid:27199510 |